Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
EIKN on Nasdaq
There are no Buy or Sell transactions made by Foresite Capital Management IV, LLC since 11 Mar 2025
Holdings reported by Foresite Capital Management IV, LLC for Eikon Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,318,983 |
|
|
04 Feb 2026 |
Indirect |
|
|
| Warrants |
34,185 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
| Series A-1 Preferred Stock |
0 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
| Series A Preferred Stock |
0 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
| Series B-1 Preferred Stock |
0 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
| Series C-1 Preferred Stock |
0 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
| Series C Preferred Stock |
0 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
| Series D Preferred Stock |
0 |
|
|
04 Feb 2026 |
Indirect |
Common Stock |
|
Transactions reported by Foresite Capital Management IV, LLC for Eikon Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.